Investing Profile

Doron Dinstein

Advisor
Venture Partner, Healthcare at Entrée Capital
Israel
Photo of Doron Dinstein, Venture Partner at Entrée Capital Ventures

Signal uses Gmail to reveal intro paths. Email content is never read.

Sign in with Google →
Northwestern University - Kellogg School of Management Network
235 CONNECTIONS
Tel Aviv University Network
223 CONNECTIONS
Entrée capital Network
11 CONNECTIONS
cb
Entrée Capital Ventures Venture Partner
Entrée capital Venture Partner, Healthcare
1
$650M
CompanyStageDateRound SizeTotal Raised
Sweetch
Series AJul 2021$20M
$33M
Co-investors: Ron Stern (OurCrowd)
Manager of Cardiovascular Applications ZOLL ItamarPresent
VP Marketing Magnolia Medical TechnologiesPresent
VP Business Development Magnolia Medical TechnologiesPresent
Chief Medical Officer Magnolia Medical TechnologiesPresent
Medical Director Magnolia Medical TechnologiesPresent
Observer, Board of Directors Omnix MedicalPresent
Board Member SweetchPresent
Head of Strategy LiteBCPresent
Head of Strategy Vortex ImagingPresent
Co-founder & CEO Magnolia Medical TechnologiesPresent
Venture Partner, Healthcare Entrée CapitalPresent
Venture Partner, Healthcare Entrée capital2020 - 2022
Tel Aviv University MD Medicine
Northwestern University - Kellogg School of Management MBA International Executive MBA program, Kellogg-Recanati 12 (class of 2009)
Sign in with Google →
Sign in with Google →